Open House Drug Discount Agreements Dimethylfumarate, ATC L04AX07

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 583 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Dimethylfumarat, ATC L04AX07

50/100

Score d'opportunité

Needs reviewLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or maximum framework value is provided. The financial potential of the agreement cannot be assessed.

Agreements automatically expire if a standard discount contract for Dimethylfumarate is concluded at federal or state l...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until May 2028
Pharmaceutical companies can enter into non-exclusive discount agreements for Dimethylfumarate (ATC L04AX07) with AOK Bayern.
Agreements are identical for all participants, not individually negotiated.

Afficher le résumé complet

This is an open-house model (non-exclusive) for pharmaceutical companies to enter into identical discount agreements for the active substance Dimethylfumarate (ATC L04AX07) with AOK Bayern. Contracts run from 01.06.2026 to 31.05.2028 and can be terminated monthly. Eligibility requires a signed declaration of reliability. No estimated value is provided. The procedure is not subject to standard procurement law.

Risques

No estimated value or maximum framework value is provided. The financial potential of the agreement cannot be assessed.

Agreements automatically expire if a standard discount contract for Dimethylfumarate is concluded at federal or state l...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

Must be a pharmaceutical company.

Administrative

Submit signed declaration of reliability.
Submit signed contract and annex listing pharmaceutical products.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Drug Discount Agreements Dimethylfumarate, ATC L04AX07

Non-exclusive discount agreements for Dimethylfumarate. All pharmaceutical companies meeting eligibility can participate. Contracts identical, not individually negotiated. Early start 01.06.2026, end 31.05.2028. Monthly entry possible until 03.04.2028.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2026 - May 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Apr 03, 2028

Détails de la procédure

Date de publication: 14 Apr 2026
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 254783-2026

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3